Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study

Details

Database :

OAIster

Journal :

Nielsen , LK , Stege , C , Lissenberg-Witte , B , van der Holt , R , Mellqvist , UH , Salomo , M , Bos , G , Levin , MD , Visser - Wisselaar , H , Hansson , M , van der Velden , A , Deenik , W , Coenen , J , Hinge , M , Klein , S , Tanis , B , Szatkowski , D , Brouwer , R , Westerman , M , Leys , R , Sinnige , H , Haukas , E , van der Hem , K , Durian , M , Gimsing , P , van de Donk , N , Sonneveld , P , Waage , A , Abildgaard , N & Zweegman , S 2020 , ' Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study ' , Haematologica , vol. 105 , no. 6 , pp. 1650-1659 .

Notes :

application/pdf, English

Publication Type :

Electronic Resource

Accession number :

edsoai.on1313628586

Document Type :

Electronic Resource